62729c28-figure-01 (62729c28 Figure 01)
Chemical structure of zonisamide, depicting its benzisoxazole core with a sulfonamide group attached.*
Zonisamide Capsule
Product Images NDC 50268-816
3 FDA label images from Avpak · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zonisamide (NDC 50268-816). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
62729c28-figure-02 (62729c28 Figure 02)
A line graph comparing the percentage reduction in all partial seizures rate between two treatment arms, Zonegran and Placebo. The vertical axis measures percent reduction in seizures rate, indicating improvement or worsening, while the horizontal axis shows the percent of patients. The Zonegran treatment arm shows a generally greater reduction in seizures compared to Placebo over the range of patients.*
Label (Screen Shot 2014 07 07 At 10.09.02 Am)
Zonisamide Capsules USP 100 mg oral capsules packaging label from AvPAK. The label indicates a count of 50 capsules (5 x 10) unit dose, with a barcode and NDC 50268-816-15. It includes usage instructions and a caution to keep out of reach of children, along with storage guidelines.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
